PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 20, 2026RSC AdvancesOpen Access

Copper-hollow mesoporous polydopamine-polyacrylic acid nanoplatform enabling photoacoustic imaging-guided photothermal/chemodynamic therapy for osteosarcoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHaoyu SunLZLiu ZBCBowen Chen

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates enhanced imaging and therapy for osteosarcoma, suggesting improved treatment options.

Key Points

  • This research aims to investigate a nanoplatform that combines imaging with targeted therapy for osteosarcoma.
  • Utilized HMPDA-Cu@PAA nanozymes for photoacoustic imaging and therapy.
  • Analyzed GSH-responsive Cu2+/Cu+ redox cycling effects on treatment efficacy.
  • Focused on photoacoustic imaging (PAI)-guided chemodynamic and photothermal therapy.
  • HMPDA-Cu@PAA nanozymes significantly improved photoacoustic imaging quality.
  • Demonstrated effective tumor reduction through combined chemodynamic and photothermal therapies.
  • Achieved enhanced therapeutic outcomes in osteosarcoma models.

Cite This Study

Sun et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4f34f03e14405aa9a78ahttps://doi.org/10.1039/d6ra01369d
View Full Paper
Ask AI
Bookmark
Share